As of January 22, 2025, Amarin Corporation (AMRN) has a market cap of $0.22 billion USD. According to our data, Amarin Corporation is ranked No.6992 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.22 B |
11.59%
|
Dec 31, 2024 | $0.20 B |
-43.68%
|
Dec 29, 2023 | $0.36 B |
-28.10%
|
Dec 30, 2022 | $0.50 B |
-64.09%
|
Dec 31, 2021 | $1.39 B |
-31.08%
|
Dec 31, 2020 | $2.01 B |
-77.19%
|
Dec 31, 2019 | $8.82 B |
57.53%
|
Dec 31, 2018 | $5.60 B |
239.40%
|
Dec 29, 2017 | $1.65 B |
30.19%
|
Dec 30, 2016 | $1.27 B |
62.96%
|
Dec 31, 2015 | $0.78 B |
92.86%
|
Dec 31, 2014 | $0.40 B |
-50.25%
|
Dec 31, 2013 | $0.81 B |
-75.65%
|
Dec 31, 2012 | $3.33 B |
8.01%
|
Dec 30, 2011 | $3.08 B |
-8.66%
|
Dec 31, 2010 | $3.37 B |
473.43%
|
Dec 31, 2009 | $0.59 B |
101.41%
|
Dec 31, 2008 | $0.29 B |
-72.69%
|
Dec 31, 2007 | $1.07 B |
-88.60%
|
Dec 29, 2006 | $9.38 B |
90.00%
|
Dec 30, 2005 | $4.94 B |
-55.72%
|
Dec 31, 2004 | $11.15 B |
75.97%
|
Dec 31, 2003 | $6.33 B |
-61.40%
|
Dec 31, 2002 | $16.41 B |
-77.03%
|
Dec 31, 2001 | $71.45 B |
215.82%
|
Dec 29, 2000 | $22.62 B |
15.79%
|
Dec 31, 1999 | $19.54 B |
33.33%
|
Dec 31, 1998 | $14.65 B |
-88.60%
|
Dec 31, 1997 | $128.54 B |
-46.24%
|
Dec 31, 1996 | $239.09 B |
-35.42%
|
Dec 29, 1995 | $370.20 B |
38.46%
|
Dec 30, 1994 | $267.37 B |
-25.71%
|
Dec 31, 1993 | $359.92 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Merck
MRK
|
$242.04 B |
-0.000 M
|
USA
|
Novartis
NVS
|
$196.27 B |
-0.007 M
|
Switzerland
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
AbbVie
ABBV
|
$299.00 B |
-0.007 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$24.96 B |
19.808 M
|
Israel
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Market Cap | = | AMRN Stock Price | * | AMRN Shares Outstanding |
= | $0.55 | * | 0.41 B | |
= | $0.22 B |